Literature DB >> 15930267

Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity.

Alexey Palamarchuk1, Alexey Efanov, Vadim Maximov, Rami I Aqeilan, Carlo M Croce, Yuri Pekarsky.   

Abstract

The helix-loop-helix transcription factor Tal1 is required for blood cell development and its activation is a frequent event in T-cell acute lymphoblastic leukemia. The Akt (protein kinase B) kinase is a key player in transduction of antiapoptotic and proliferative signals in T cells. Because Tal1 has a putative Akt phosphorylation site at Thr90, we investigated whether Akt regulates Tal1. Our results show that Akt specifically phosphorylates Thr90 of the Tal1 protein within its transactivation domain in vitro and in vivo. Coimmunoprecipitation experiments showed the presence of Tal1 in Akt immune complexes, suggesting that Tal1 and Akt physically interact. We further showed that phosphorylation of Tal1 by Akt causes redistribution of Tal1 within the nucleus. Using luciferase assay, we showed that phosphorylation of Tal1 by Akt decreased repressor activity of Tal1 on EpB42 (P4.2) promoter. Thus, these data indicate that Akt interacts with Tal1 and regulates Tal1 by phosphorylation at Thr90 in a phosphatidylinositol 3-kinase-dependent manner.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930267     DOI: 10.1158/0008-5472.CAN-05-0751

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  5 in total

1.  Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL).

Authors:  Alexey Palamarchuk; Pearlly S Yan; Nicola Zanesi; Linan Wang; Benjamin Rodrigues; Mark Murphy; Veronica Balatti; Arianna Bottoni; Natalya Nazaryan; Hansjuerg Alder; Laura Rassenti; Thomas J Kipps; Michael Freitas; Carlo M Croce; Yuri Pekarsky
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

2.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

3.  Cell-intrinsic adaptation of lipid composition to local crowding drives social behaviour.

Authors:  Mathieu Frechin; Thomas Stoeger; Stephan Daetwyler; Charlotte Gehin; Nico Battich; Eva-Maria Damm; Lilli Stergiou; Howard Riezman; Lucas Pelkmans
Journal:  Nature       Date:  2015-05-25       Impact factor: 49.962

4.  The vascular bone marrow niche influences outcome in chronic myeloid leukemia via the E-selectin - SCL/TAL1 - CD44 axis.

Authors:  Parimala Sonika Godavarthy; Rahul Kumar; Stefanie C Herkt; Raquel S Pereira; Nina Hayduk; Eva S Weissenberger; Djamel Aggoune; Yosif Manavski; Tina Lucas; Kuan-Ting Pan; Jenna M Voutsinas; Qian Wu; Martin C Müller; Susanne Saussele; Thomas Oellerich; Vivian G Oehler; Joern Lausen; Daniela S Krause
Journal:  Haematologica       Date:  2019-04-24       Impact factor: 9.941

5.  The Role of TAL1 in Hematopoiesis and Leukemogenesis.

Authors:  E R Vagapova; P V Spirin; T D Lebedev; V S Prassolov
Journal:  Acta Naturae       Date:  2018 Jan-Mar       Impact factor: 1.845

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.